ConductScience.org, home

Trial · NCT02981446

Results by group22

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Mean Diurnal IOP at Month 3DE-117 Ophthalmic Solution17.5Standard Error 0.25mmHg
Mean Diurnal IOP at Month 3Latanoprost Ophthalmic Solution 0.005%16.8Standard Error 0.25mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 1 09:0019.0Standard Error 0.28mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 1 09:0018.8Standard Error 0.29mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 1 13:0018.4Standard Error 0.28mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 1 13:0018.4Standard Error 0.29mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 1 17:0018.0Standard Error 0.28mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 1 17:0018.3Standard Error 0.28mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 6 09:0017.8Standard Error 0.26mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 6 09:0017.4Standard Error 0.26mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 6 13:0017.6Standard Error 0.27mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 6 13:0017.2Standard Error 0.27mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionWeek 6 17:0017.5Standard Error 0.26mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Week 6 17:0017.1Standard Error 0.27mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionMonth 3 09:0017.9Standard Error 0.27mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Month 3 09:0017.0Standard Error 0.27mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionMonth 3 13:0017.2Standard Error 0.25mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Month 3 13:0016.7Standard Error 0.26mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)DE-117 Ophthalmic SolutionMonth 3 17:0017.2Standard Error 0.26mmHg
IOP at 9 Timepoints (First Key Secondary Efficacy Endpoint)Latanoprost Ophthalmic Solution 0.005%Month 3 17:0016.7Standard Error 0.27mmHg

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02981446/results